Unknown

Dataset Information

0

The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-?B pathway and proinflammatory factors in vascular smooth muscle cells.


ABSTRACT: Connective tissue growth factor (CTGF/CCN2) is a developmental gene upregulated in pathological conditions, including cardiovascular diseases, whose product is a matricellular protein that can be degraded to biologically active fragments. Among them, the C-terminal module IV [CCN2(IV)] regulates many cellular functions, but there are no data about redox process. Therefore, we investigated whether CCN2(IV) through redox signaling regulates vascular responses.CCN2(IV) increased superoxide anion (O2(•-)) production in murine aorta (ex vivo and in vivo) and in cultured vascular smooth muscle cells (VSMCs). In isolated murine aorta, CCN2(IV), via O2(•-), increased phenylephrine-induced vascular contraction. CCN2(IV) in vivo regulated several redox-related processes in mice aorta, including increased nonphagocytic NAD(P)H oxidases (Nox)1 activity, protein nitrosylation, endothelial dysfunction, and activation of the nuclear factor-?B (NF-?B) pathway and its related proinflammatory factors. The role of Nox1 in CCN2(IV)-mediated vascular responses in vivo was investigated by gene silencing. The administration of a Nox1 morpholino diminished aortic O2(•-) production, endothelial dysfunction, NF-?B activation, and overexpression of proinflammatory genes in CCN2(IV)-injected mice. The link CCN2(IV)/Nox1/NF-?B/inflammation was confirmed in cultured VSMCs. Epidermal growth factor receptor (EGFR) is a known CCN2 receptor. In VSMCs, CCN2(IV) activates EGFR signaling. Moreover, EGFR kinase inhibition blocked vascular responses in CCN2(IV)-injected mice.CCN2(IV) is a novel prooxidant factor that in VSMCs induces O2(•-) production via EGFR/Nox1 activation. Our in vivo data demonstrate that CCN2(IV) through EGFR/Nox1 signaling pathway induces endothelial dysfunction and activation of the NF-?B inflammatory pathway. Therefore, CCN2(IV) could be considered a potential therapeutic target for redox-related cardiovascular diseases.

SUBMITTER: Rodrigues-Diez RR 

PROVIDER: S-EPMC4270131 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Rodrigues-Diez Raúl R RR   Garcia-Redondo Ana Belen AB   Orejudo Macarena M   Rodrigues-Diez Raquel R   Briones Ana Maria AM   Bosch-Panadero Enrique E   Kery Gyorgy G   Pato Janos J   Ortiz Alberto A   Salaices Mercedes M   Egido Jesus J   Ruiz-Ortega Marta M  

Antioxidants & redox signaling 20150101 1


<h4>Aims</h4>Connective tissue growth factor (CTGF/CCN2) is a developmental gene upregulated in pathological conditions, including cardiovascular diseases, whose product is a matricellular protein that can be degraded to biologically active fragments. Among them, the C-terminal module IV [CCN2(IV)] regulates many cellular functions, but there are no data about redox process. Therefore, we investigated whether CCN2(IV) through redox signaling regulates vascular responses.<h4>Results</h4>CCN2(IV)  ...[more]

Similar Datasets

| S-EPMC5400225 | biostudies-literature
| S-EPMC3229221 | biostudies-literature
| S-EPMC112537 | biostudies-literature
| S-EPMC8156007 | biostudies-literature
| S-EPMC3900988 | biostudies-literature
| S-EPMC3606394 | biostudies-literature
| S-EPMC3527765 | biostudies-literature
| S-EPMC7476810 | biostudies-literature
| S-EPMC2728961 | biostudies-literature
| S-EPMC4516546 | biostudies-literature